SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Evanguelos Xylinas, Luis A. Kluth, Yair Lotan, Siamak Daneshmand, Malte Rieken, Pierre I. Karakiewicz, Shahrokh F. Shariat, Blood- and tissue-based biomarkers for prediction of outcomes in urothelial carcinoma of the bladder, Urologic Oncology: Seminars and Original Investigations, 2014, 32, 3, 230

    CrossRef

  2. 2
    A. P. Mitra, L. L. Lam, M. Ghadessi, N. Erho, I. A. Vergara, M. Alshalalfa, C. Buerki, Z. Haddad, T. Sierocinski, T. J. Triche, E. C. Skinner, E. Davicioni, S. Daneshmand, P. C. Black, Discovery and Validation of Novel Expression Signature for Postcystectomy Recurrence in High-Risk Bladder Cancer, JNCI Journal of the National Cancer Institute, 2014, 106, 11, dju290

    CrossRef

  3. 3
    Anirban P. Mitra, Eila C. Skinner, Anne K. Schuckman, David I. Quinn, Tanya B. Dorff, Siamak Daneshmand, Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: A critical analysis of 1,994 patients, Urologic Oncology: Seminars and Original Investigations, 2014, 32, 1, 52.e1

    CrossRef

  4. 4
    Yasuyoshi Miyata, Shigeru Kanda, Kensuke Mitsunari, Akihiro Asai, Hideki Sakai, Heme oxygenase-1 expression is associated with tumor aggressiveness and outcomes in patients with bladder cancer: a correlation with smoking intensity, Translational Research, 2014, 164, 6, 468

    CrossRef

  5. 5
    Nikhil Sapre, Praduymna Herle, Paul D. Anderson, Niall M. Corcoran, Christopher M. Hovens, Molecular biomarkers for predicting outcomes in urothelial carcinoma of the bladder, Pathology, 2014, 46, 4, 274

    CrossRef

  6. 6
    Rosário Pinto-Leite, Regina Arantes-Rodrigues, Rita Ferreira, Carlos Palmeira, Paula A. Oliveira, Lúcio Santos, Treatment of muscle invasive urinary bladders tumors: A potential role of the mTOR inhibitors, Biomedicine & Aging Pathology, 2014, 4, 3, 169

    CrossRef

  7. 7
    Margareta Randén, Maria Helde-Frankling, Sara Runesdotter, Peter Gunvén, Unfavorable cancers of unknown primaries: presentation and prognostic factors. A population-based 8-year experience, Medical Oncology, 2013, 30, 4

    CrossRef